No serious evidence of graphene in Pfizer vaccine

.
.
.

A rumor, widely relayed on social networks recently, claimed that graphene would be present in Pfizer’s vaccine. After examination, it turns out that this claim is baseless1See in particular:
In French :
Covid-19 vaccine: Beware, these videos do not show “graphene”, France 24, 3 August 2021
Vaccination: no, “Spanish researchers” have not shown that Pfizer “contains an unknown product”, LCI, 8 July 2021
Covid-19 disinfox: no, no study proves Pfizer vaccine contains graphene, Le Progrès, 15 July 2021
.

Upcoming Nano Agenda

1
Déc.
2025
Controlling the risks associated with nanomaterials (CEA, Online)
On line
Training
  • E-learning program: awareness-raising for personnel who come into contact with nanomaterials during research, formulation, production, maintenance, cleaning, upkeep, etc., as well as safety coordinators or engineers, facility managers, heads of laboratories where nanoparticles are handled.
  • Organizers: INSTN Grenoble (CEA)
  • On the program:
    • 1 – Introduction, definition and characteristics of nanomaterials
    • 2 – Toxicity of nanomaterials: the state of knowledge
    • 3 – Metrology and characterization of nanomaterials
    • 4 – Prevention and protection against nanomaterials in the workplace
    • 5 – Quiz: assessment of learning outcomes
  • The 2-hour course can be viewed for one month from the date of registration.
  • Website: https://instn.cea.fr/…risques-lies-aux-nanomateriaux…
9
Déc.
2025
Annual conference of GdR NaMasTE (CNRS, Grenoble – France)
Grenoble
Colloquium
  • Annual conference of the NaMasTE research group (Manufactured Nanomaterials, Toxicology, Ecotoxicology and Risks: towards controlled development)
  • Dates: December 9 and 10, 2025
  • Organizers: CNRS
  • Website: https://namaste2025.sciencesconf.org

2
Juin
2026
Emerging pathologies and risks (CNMST 2026, Lyon – France)
Lyon
Congress
health
health
occupational health
prevention
risks
  • 8th Congress of Occupational Medicine and Health (CNMST 2026)
  • Theme 5: Emerging pathologies and risks, Mr Henri Bastos (ANSES), Pr Lynda Bensefa-Colas (AP-HP), Dr Catherine Nisse (CHU Lille)
  • Website: www.medecine-sante-travail.com

Notes and references